Coverage
-
February 13, 2018
The Eleventh Circuit failed to consider several issues when it ruled in favor of Amgen Inc., Pfizer Inc. and Wyeth Inc. in a lawsuit brought by a woman claiming their arthritis drug, Enbrel, caused severe infections, according to a motion for rehearing filed Monday.
1 other articles on this case.
View all »